News
12d
Stockhead on MSNBiocurious: Lumos shines a light on the post-pandemic rapid diagnosis sectorLumos Diagnostics is striving to become the leader in rapid point-of-care tests to distinguish between viral and bacterial ...
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Lumos Diagnostics Holdings Limited's (ASX:LDX) case, it's fantastic news ...
Dear Abby advises a newly engaged man who has concerns about how his fiancée is treating him more like a child, instead of an ...
Pallante misplaced his shutout bid in the eighth inning, but the bullpen holds tight for a 4-2 victory against Washington and ...
AI-powered platform ensures the right people and AI agents have the right access for the right time — reducing security risks, unlocking productivity, and driving profitability Lumos' new ...
Jet lag can wreck a trip, but a few smart apps and gadgets can help you adjust faster and enjoy more of your vacation without ...
Special Report: Lumos Diagnostics is continuing to advance the US reimbursement pathway for its FebriDx test, a rapid point-of-care diagnostic designed to differentiate between bacterial and non ...
11d
Stockhead on MSNASX Quarterly Health Wrap: Control Bionics reports strong US revenue, LTR Pharma makes progress with FDAControl Bionics, LTR Pharma and Lumos Diagnostics are among ASX health companies reporting strong quarterly results this week ...
Stockhead on MSN18d
Medicare coverage advances for Lumos’ FebriDx point-of-care respiratory testSpecial Report: Lumos Diagnostics is continuing to advance the US reimbursement pathway for its FebriDx test, a rapid point-of-care diagnostic designed to differentiate between bacterial and ...
Border officers in Arizona prevented a possible child-trafficking attempt recently after they apprehended a man with alleged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results